Biomarker-guided Sequencing
Biomarker-Guided Sequencing is a treatment strategy in immuno-oncology that uses specific molecular or cellular biomarkers to determine the optimal order of therapeutic interventions based on their predictive value for patient response.
14
Publications
2.1K
Citations
233
Authors
81
Institutions
Publications per year
2017–2026
11
14
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Rebecca Leary, Isaac Kinde, Frank Diehl et al. · Science Translational Medicine · 2010 · 517 citations · Full text
Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing
Nirali M. Patel, Vanessa V. Michelini, Jeff M. Snell et al. · The Oncologist · 2017 · 106 citations · Full text
1–5 of 14
233
1
h-index
1
h-index
1
h-index
1
h-index
Institute for Health Metrics and Evaluation, United States
1 publications · 101 citations
1
h-index
1–5 of 233
81
Harvard University
Cambridge, United States
3 h-index
3 publications
86 citations
Dana-Farber Cancer Institute
Boston, United States
2 h-index
4 publications
167 citations
University of California, Los Angeles
Los Angeles, United States
2 h-index
5 publications
365 citations
Case Western Reserve University
Cleveland, United States
2 h-index
8 publications
339 citations

McMaster University
Hamilton, Canada
2 h-index
2 publications
113 citations

Howard Hughes Medical Institute
Chevy Chase, United States
2 h-index
10 publications
5.4K citations

University of British Columbia
Vancouver, Canada
1 h-index
1 publications
12 citations
Bharathidasan University
Tiruchchirappalli, India
1 h-index
1 publications
637 citations
1–8 of 81
STM · 2 publications · 1.2K citations
2
h-index
2 publications · 126 citations
2
h-index
1 publications · 477 citations
1
h-index
1 publications · 66 citations
1
h-index
1 publications · 101 citations
1
h-index
1–5